BPC-157 for Gut Problems: What Has Been Tested in Humans?

If you live with cramping, diarrhea or bowel inflammation and wonder what BPC-157 has done for gut problems in people, the tested record is almost empty. One company started a formal ulcerative colitis trial in the early 2000s after a small safety test, but it never published patient results. The rest of the bowel story comes from animals.

What happened to the ulcerative colitis trial?

Croatian drug company Pliva tested a form of BPC-157 called PL14736 for ulcerative colitis, a long term condition that causes inflammation and sores in the colon. A Phase I test, which checks safety in healthy volunteers, found no safety problems in 32 people, and the company then started a Phase II test, which tests whether patients improve ghost-trial account.

No journal article, meeting abstract or press release ever reported the Phase II results ghost-trial account. A 2012 review from the Zagreb group behind the work said the bowel effect had so far only been tested in clinical phase II, and it described no toxic effect in safety testing and no side effects in trials 2012 Zagreb review.

Is there any other human gut data?

A 2025 systematic review counted 35 animal studies and one uncontrolled 16-patient chart review as the full evidence base for BPC-157 2025 review summary. In that chart review, doctors looked back at records without a comparison group, so the records cannot show whether BPC-157 caused any change.

BPC-157 has no FDA approved use for gut problems or any other condition, and FDA placed it in Category 2 for compounding in September 2023, which bars licensed United States pharmacies from preparing it regulatory summary. In April 2026 the United Kingdom medicines regulator opened an inquiry into clinics that market unlicensed compounds and named BPC-157 first. The regulator said little credible scientific evidence sat behind the health claims U.K. inquiry report.

What animal gut studies show and why they do not settle it

In rats with an abnormal tunnel between the colon and the skin that leaked, BPC-157 given by mouth or by injection helped the tunnel close. Researchers saw closure with the eye and under the microscope, and the repaired colon held more water without leaking rat fistula study. In the same test, sulphasalazine helped only moderately and a steroid made healing worse rat fistula study.

Rats do not tell us how you will respond if you have ulcerative colitis, Crohn disease or ongoing bowel symptoms. Consultant gastroenterologist Dr. Pranab Gyawali, who has treated Crohn disease and ulcerative colitis for 25 years, says he does not recommend BPC-157 for bowel disease and remains highly skeptical. He links the surge of interest to wellness blogs, Reddit and peptide clinics Dubai gastroenterologist opinion.